NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028

Lifesciences | Healthcare & Wellness

NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028

Market by Drug Class, Application, and Country | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton Market Research has concluded that the North America dermatological therapeutics market would grow at a CAGR of 7.76% in the estimated years 2019-2028.


Report scope can be customized per your requirements. Request For Customization

The countries evaluated in this market include:

•           The United States

•           Canada

The growing burden of skin-related diseases and the increase in the elderly populace are primarily driving the growth of the United States dermatological therapeutics market. Dermatological disorders are among the most common health issues plaguing US nationals. Also, atopic dermatitis, which mainly affects children, was reported by the Asthma and Allergy Foundation of America to have affected nearly 7.3% of the adults in the country, in 2018. And out of the total number of individuals affected, 40% were at moderate or severe stages. Thus, the increase in cases of skin disorders is likely to increase the adoption of dermatological treatments, and consequently propel the dermatological therapeutics market growth in the US.

Further, it must be noted that, aging and skin disorders are directly related. The rise in the older population and the enhanced expenditure on dermatological treatments are expected to push the market growth to a higher level. According to the National Population Projections report by the US Census Bureau released in 2017, approximately 77 million people in the country will be aged 65 years and above by 2034. Also, the median age of the US population, which was 38 years in 2017, is expected to rise to 43 years by 2060. With old age, people are more prone to dermatological diseases. Hence, they are increasingly opting for treatment therapies. This has raised the demand for dermatological therapeutics, in turn, propelling the growth of the studied market in the United States, over the forecasting period.

Bausch Health Companies Inc, formerly known as Valeant Pharmaceuticals, specialty pharmaceutical company engaged in developing and introducing new treatments. It focuses on several therapeutic areas, including dermatology. Arazlo and Bryhali are among its popular products in the dermatological therapeutics segment. The former is used for treating acne vulgaris; whereas, the latter is given to patients suffering from psoriasis, to relieve them from itching, dryness, inflammation, etc. Bausch Health is headquartered in Quebec, Canada.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. KEY INSIGHTS

2.2.1.   ADVANCEMENTS IN BIOLOGICS

2.2.2.   ATOPIC DERMATITIS IS ANTICIPATED TO GROW AT HIGHEST CAGR

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1.   THREAT OF NEW ENTRANTS

2.3.2.   THREAT OF SUBSTITUTE

2.3.3.   BARGAINING POWER OF SUPPLIERS

2.3.4.   BARGAINING POWER OF BUYERS

2.3.5.   THREAT OF COMPETITIVE RIVALRY

2.4. IMPACT OF COVID-19 – DERMATOLOGICAL THERAPEUTICS

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. MARKET DRIVERS

2.7.1.   INCREASING BURDEN OF DERMATOLOGICAL DISEASES

2.8. MARKET RESTRAINTS

2.8.1.   GRAVE SIDE-EFFECTS FOR CERTAIN CLASSES OF THERAPEUTIC DRUGS

2.9. MARKET OPPORTUNITIES

2.9.1.   RISE IN AWARENESS LEVELS OF DISEASE ORIGIN AND PROGRESSION

2.10. MARKET CHALLENGES

2.10.1.   UNAWARENESS TOWARDS DERMATOLOGICAL DIAGNOSIS

3. NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET OUTLOOK – BY DRUG CLASS

3.1. ANTI-INFECTIVES

3.2. CORTICOSTEROIDS

3.3. ANTI-ACNE

3.4. CALCINEURIN INHIBITORS

3.5. RETINOIDS

3.6. OTHER DRUG CLASSES

4. NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET OUTLOOK - BY APPLICATION

4.1. ALOPECIA

4.2. HERPES

4.3. PSORIASIS

4.4. ROSACEA

4.5. ATOPIC DERMATITIS

4.6. ACNE VULGARIS

4.7. OTHER APPLICATIONS

5. NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET – REGIONAL OUTLOOK

5.1. NORTH AMERICA

5.1.1.   UNITED STATES

5.1.2.   CANADA

6. COMPETITIVE LANDSCAPE

6.1. ABBVIE INC

6.2. ALLERGAN

6.3. ALMIRALL

6.4. AMGEN INC

6.5. BAUSCH HEALTH COMPANIES INC

6.6. GALDERMA

6.7. GLAXOSMITHKLINE PLC

6.8. JOHNSON & JOHNSON

6.9. NOVARTIS AG

6.10. PFIZER INC

6.11. AGI DERMATICS

6.12. LEO PHARMA A/S

6.13. MERCK & CO

7. METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.2. SOURCES OF DATA

7.3. RESEARCH METHODOLOGY

List of table

TABLE 1: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)

TABLE 2: MARKET ATTRACTIVENESS INDEX

TABLE 3: VENDOR SCORECARD

TABLE 4: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)

TABLE 5: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, 2019-2028 (IN $ BILLION)

TABLE 6: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2028 (IN $ BILLION)

List of Figures

FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

FIGURE 2: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-INFECTIVES, 2019-2028 (IN $ BILLION)

FIGURE 3: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY CORTICOSTEROIDS, 2019-2028 (IN $ BILLION)

FIGURE 4: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-ACNE, 2019-2028 (IN $ BILLION)

FIGURE 5: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY CALCINEURIN INHIBITORS, 2019-2028 (IN $ BILLION)

FIGURE 6: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY RETINOIDS, 2019-2028 (IN $ BILLION)

FIGURE 7: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER DRUG CLASSES, 2019-2028 (IN $ BILLION)

FIGURE 8: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ALOPECIA, 2019-2028 (IN $ BILLION)

FIGURE 9: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY HERPES, 2019-2028 (IN $ BILLION)

FIGURE 10: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY PSORIASIS, 2019-2028 (IN $ BILLION)

FIGURE 11: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ROSACEA, 2019-2028 (IN $ BILLION)

FIGURE 12: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ATOPIC DERMATITIS, 2019-2028 (IN $ BILLION)

FIGURE 13: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ACNE VULGARIS, 2019-2028 (IN $ BILLION)

FIGURE 14: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ BILLION)

FIGURE 15: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)

FIGURE 16: UNITED STATES DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 17: CANADA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;